ACUMEN PHARMACEUTICALS
Acumen is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target amyloid-beta oligomers, (AฮฒOs), which Acumen believes to be a key underlying cause of Alzheimerโs disease, or AD. Acumen is currently focused on advancing a targeted immunotherapy drug candidate, ACU193, to establish proof of mechanism in early AD patients. Acumen initiated its Phase 1 clinical trial of ACU193 in the second quarter of 2021 with the objective to evaluate its safety and ... tolerability and explore its pharmacokinetics and target engagement. This trial is currently enrolling patients with mild cognitive impairment and mild dementia due to AD. ACU193 Phase 1 data intended to evaluate safety and tolerability and demonstrate clinical proof of mechanism are expected by year end 2022.
ACUMEN PHARMACEUTICALS
Social Links:
Industry:
Biotechnology Health Diagnostics Therapeutics
Founded:
1996-01-01
Address:
Carmel, Indiana, United States
Country:
United States
Website Url:
http://www.acumenpharm.com
Total Employee:
11+
Status:
Active
Contact:
+1 6508757772
Email Addresses:
[email protected]
Total Funding:
115.1 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Tag Manager WordPress Wordpress Plugins Sitelinks Search Box Microsoft Exchange Online
Similar Organizations
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Spero Therapeutics
Spero Therapeutics is developing first in class therapeutics for treatment of gram-negative infections.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
PBM Capital Group
PBM Capital Group investment in Series B - Acumen Pharmaceuticals
RA Capital Management
RA Capital Management investment in Series B - Acumen Pharmaceuticals
Rock Springs Capital
Rock Springs Capital investment in Series B - Acumen Pharmaceuticals
BlackRock
BlackRock investment in Series B - Acumen Pharmaceuticals
Sands Capital Ventures
Sands Capital Ventures investment in Series B - Acumen Pharmaceuticals
PBM Capital Group
PBM Capital Group investment in Series A - Acumen Pharmaceuticals
Sands Capital Ventures
Sands Capital Ventures investment in Series A - Acumen Pharmaceuticals
National Institute on Aging
National Institute on Aging investment in Grant - Acumen Pharmaceuticals
NeuroVentures
NeuroVentures investment in Venture Round - Acumen Pharmaceuticals
Official Site Inspections
http://www.acumenpharm.com Semrush global rank: 8.36 M Semrush visits lastest month: 321
Unable to get host informations!!!
